Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VTX-3232 by Ventyx Biosciences for Neuroinflammation: Likelihood of Approval
VTX-3232 is under clinical development by Ventyx Biosciences and currently in Phase I for Neuroinflammation. According to GlobalData, Phase I...
VTX-3232 by Ventyx Biosciences for Parkinson's Disease: Likelihood of Approval
VTX-3232 is under clinical development by Ventyx Biosciences and currently in Phase II for Parkinson's Disease. According to GlobalData, Phase...
VTX-3232 by Ventyx Biosciences for Multiple Sclerosis: Likelihood of Approval
VTX-3232 is under clinical development by Ventyx Biosciences and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase...